PPAR-gamma: a transcription factor, member of the nuclear hormone receptor superfamily. Receptor for hypolipidemic drugs and fatty acids. Preferentially expressed in adipocytes as well as in vascular smooth muscle cells and macrophage. Regulator of adipogenesis and lipid metabolism, modulates insulin sensitivity, cell proliferation and inflammation. Phosphorylated and inhibited by MAP kinase. Heterodimerizes with the retinoid X receptor. Interacts with NCOA6 coactivator, leading to a strong increase in transcription of target genes. Two splice-variant isoforms have been described.
Protein type: DNA-binding; Nuclear receptor
Chromosomal Location of Human Ortholog: 3p25.2
Cellular Component: cytosol; intracellular membrane-bound organelle; nucleoplasm; nucleus; perinuclear region of cytoplasm; protein complex; RNA polymerase II transcription factor complex
Molecular Function: activating transcription factor binding; alpha-actinin binding; arachidonic acid binding; chromatin binding; DBD domain binding; DNA binding; DNA binding transcription factor activity; double-stranded DNA binding; drug binding; enzyme binding; estrogen receptor binding; identical protein binding; LBD domain binding; ligand-dependent nuclear receptor activity; ligand-dependent nuclear receptor transcription coactivator activity; peptide binding; prostaglandin receptor activity; protein binding; protein C-terminus binding; protein heterodimerization activity; protein phosphatase binding; protein self-association; retinoid X receptor binding; sequence-specific DNA binding; steroid hormone receptor activity; transcription factor binding; transcription regulatory region DNA binding; zinc ion binding
Biological Process: activation of cysteine-type endopeptidase activity involved in apoptotic process; cell fate commitment; cell maturation; cellular response to hyperoxia; cellular response to insulin stimulus; cellular response to prostaglandin E stimulus; cellular response to retinoic acid; cellular response to vitamin E; epithelial cell differentiation; fatty acid oxidation; G-protein coupled receptor signaling pathway; glucose homeostasis; heart development; innate immune response; lipid homeostasis; lipid metabolic process; lipoprotein transport; long-chain fatty acid transport; low-density lipoprotein receptor biosynthetic process; macrophage derived foam cell differentiation; monocyte differentiation; negative regulation of acute inflammatory response; negative regulation of angiogenesis; negative regulation of blood vessel endothelial cell migration; negative regulation of cell growth; negative regulation of cholesterol storage; negative regulation of collagen biosynthetic process; negative regulation of macrophage derived foam cell differentiation; negative regulation of pancreatic stellate cell proliferation; negative regulation of receptor biosynthetic process; negative regulation of sequestering of triglyceride; negative regulation of smooth muscle cell proliferation; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; negative regulation of vascular endothelial cell proliferation; organ regeneration; placenta development; positive regulation of DNA binding; positive regulation of fat cell differentiation; positive regulation of fatty acid oxidation; positive regulation of oligodendrocyte differentiation; positive regulation of phagocytosis, engulfment; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-templated; regulation of blood pressure; regulation of circadian rhythm; response to caffeine; response to cold; response to drug; response to estrogen; response to lipid; response to mechanical stimulus; response to metformin; response to nutrient; response to retinoic acid; response to starvation; response to vitamin A; rhythmic process; signal transduction; steroid hormone mediated signaling; transcription initiation from RNA polymerase II promoter; white fat cell differentiation
Disease: Carotid Intimal Medial Thickness 1; Diabetes Mellitus, Noninsulin-dependent; Lipodystrophy, Familial Partial, Type 3; Obesity
Show more